Thrivent Financial for Lutherans reduced its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 3.3% in the fourth ...

Mural Oncology (NASDAQ:MURA) stock plummets 47% as the company, a spinoff of Alkermes (ALKS) halts a Phase 3 trial for its ...

Alkermes plc (NASDAQ:ALKS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen research firms that are covering the stock, MarketBeat.com reports. Four investment ...

OptiNose, Inc. (NASDAQ:OPTN) faces a pessimistic outlook from investment analysts with a target price significantly lower than its market price. Collegium Pharmaceutical, Inc. (COLL) is perceived as ...

In a report released today, Jason Gerberry from Bank of America Securities maintained a Hold rating on Alkermes (ALKS – Research Report), with ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vicarious Surgical (RBOT – Research Report), Alkermes (ALKS ...

On St. Patrick's Day, everybody's a little Irish. Alkermes, Aon, Jazz Pharmaceuticals, PDD Holdings and CRH are five ...

Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

In this article, we are going to take a look at where Alkermes plc (NASDAQ ... Long-Term Investment Opportunities Speaking ...

In the US, healthcare expenditures and costs have been increasing. According to the Centers for Medicare & Medicaid Services, ...

New Jersey's pharmaceutical industry supports 370,000 jobs and generates $130 billion a year, or 20% of the state's economy. It already faced pushback in recent years from Democrats such as former ...